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Introduction
In recent years there has been a dramatic increase in the identification of oncogenic driver mutations in non-small cell lung cancer (NSCLC) 1 . In the non-squamous NSCLC subtype two of these driver mutations; epidermal growth factor receptor (EGFR) and the anaplastic lymphoma kinase (ALK), can be targeted by the administration of small molecule tyrosine kinase inhibitors (TKI), gefitinib and erlotinib (for EGFR) 2 and crizotinib (for ALK) 3 , all of which have demonstrated significant antitumor activity in their respective patient populations [4] [5] [6] [7] [8] [9] [10] [11] .
Specifically for the case ALK gene rearrangements, which were initially discovered in NSCLC squamous NSCLC, to select candidates for crizotinib therapy 13 . Selection of patients for crizotinib TKI therapy should be performed with an ALK fluorescent in situ hybridization (FISH) assay using dual-labelled break-apart probes.
The Vysis ALK Break Apart FISH Probe Kit was utilized to identify ALK rearrangements in NSCLC patients in Phase II and III crizotinib trials, and was co-approved by the FDA as the companion diagnostic for crizotinib therapy selection. While other assay technologies are investigated, including; real-time polymerase chain reaction (RT-PCR) 14, 15 , immunohistochemistry (IHC) [16] [17] [18] , and next-generation DNA sequencing (NGS) 19, 20 , there is a lack of clinical validation for these technologies in detecting crizotinib responders, and as such, FISH remains the gold standard technology for the detection of ALK rearrangements in NSCLC 13, 21 .
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FISH is often considered a complex, and labor intensive molecular technique, and therefore we aimed to study if workflow, and ease of interpretation improvements could be made for the ALK FISH molecular assay by; automating the front-end pretreatment of 20 formalin-fixed paraffin-embedded (FFPE) NSCLC tissue specimens for ALK FISH assaying, as well as, providing automated back-end fluorescence scanning, and interpretation algorithms for enumeration and analysis of the ALK FISH specimens. The pretreatment steps were performed using the VP 2000 instrument, investigating a number of different pretreatment protocols (see materials and methods), were-as the back-end scanning and analysis of ALK manual enumeration on scanned images to software assistant interpretation algorithms that are highly concordant with manual reading. Significant workflow possibilities were observed for the BioView instruments, as they allowed web-based consultation and comparison of difficult specimens. pepsin) was performed for 6 min at 37 C. Slides were washed in distilled water and let dry.
Materials and Methods
NSCLC Tissue Specimens
Semi-automated FISH staining of NSCLC FFPE specimens-Milan
Probes of the Vysis ALK Break Apart FISH probe kit were denatured for 1 min at 85 C, followed by overnight hybridization at 37 C using a Thermobrite (Abbott Molecular). For counterstaining, the Vectashield mounting medium with DAPI (Vector Labs, Peterborough, UK) was used. Post-hybridization washing was performed using a 2XSSC/0.3% NP-40 homebrewed solution for 2 minutes at 73 C (Abbott Molecular).
Interpretation of ALK Fluorescence in situ Hybridization
In all cases, ALK FISH was performed using the Vysis ALK Break Apart FISH probe kit provided by Abbott Molecular. For interpretation of ALK FISH status, the recommended scoring protocol was followed; where specimens were classified as positive for an ALK gene rearrangement (ALK positive) when a minimum of 25 out 50 or a minimum of 15 out of 100 tumor nuclei demonstrated a break apart and/or isolated fluorescent orange FISH signal.
Study Protocol
As ALK FISH automation was not established prior to the beginning of this study, two sets of specimens were prepared from tissue blocks that had previously been interpreted at the UZA. The first set of specimens contained ten ALK positive and ten ALK negative NSCLC specimens. These twenty specimens were sent to each study site, as a training set, along with the full enumeration and analysis results from Antwerp, in order to allow each lab to set, and concordant results at each site, a new set of blinded specimens was dispatched to allow for evaluation of the semi-automated protocol. Again at UZA, ten unique ALK positive and ten unique ALK negative NSCLC specimens were prepared. This test set of twenty specimens was then dispatched to each study site, without the results of the analysis. The test set was processed at each site using the respective semi-automation protocol, and results were compared between the sites to gauge the success of each protocol.
Back-end scanning and interpretation of ALK FISH specimens-Antwerp
At UZA, manual interpretation of the ALK FISH specimens was performed as defined in the 
Back-end scanning and interpretation of ALK FISH specimens-Lyon
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In Lyon, the specimens were analyzed using a BioView automated scanning platform, in analogy to the BioView workflow of Antwerp. The tumors cells were enumerated by the analyst in two ways: manual scoring under microscope eyepiece and automated scoring allowed by Bioview software.
Back-end scanning and interpretation of ALK FISH specimens-Rennes
In Rennes, the specimens were analyzed with a fluorescence microscope Axio Imager Z1
(Zeiss, Göttingen, Germany) and Isis imaging software (Metasystems, Altlussheim, Germany). The entire hybridized surface was screened using a double band-pass filter with an x63 objective to detect areas with abnormal patterns and to focus the scoring. FISH scoring was performed under both real-time conditions at the microscope and with the use of z-stack images.
Back-end scanning and interpretation of ALK FISH specimens-Berlin
In Berlin, for signal detection and enumeration an Axio Imager Z1 (Zeiss, Jena, Germany) and the Isis software (version 5.3.1, MetaSystems, Altlussheim, Germany) were employed.
Images were captured manually and the specimens were then enumerated on a computer screening.
Back-end scanning and interpretation of ALK FISH specimens-Milan
In Milan, the specimens were analyzed using an lkonisys automated scanning platform, 
Online specimen analysis using the BioView SoloWeb software application
As a number of sites experienced difficulties with the front-end processing of the specimens, a novel FDA cleared web based application online software, SoloWeb, was provided by BioView to allow for remote interpretation of the specimens that were successfully prepared with the manual protocol in UZA, Antwerp, and scanned with the BioView Allegro-Plus system using standard web browsers.
Results
Training Set
Twenty NSCLC specimens, ten of which were ALK FISH negative (samples 01-10), and ten which were ALK FISH positive (sample [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , were processed manually in Antwerp. Serial sections of the same specimens were dispatched to four different European centers (Rennes, Lyon, Milan and Berlin) for automated front-end specimen processing with VP
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2000, followed by manual analysis. 
Test Set
As the training set had been deployed to assess the success of the front-end pretreatment protocol, and to allow for training of a back-end system, a new set of twenty blinded, serial NSCLC specimens were sent to each site. These specimens were processed manually in
Antwerp, but the results were not shared with the sites. Each site then utilized their respective VP 2000 protocol for the front-end automation, and their respective back-end scanning protocol to elucidate the ALK status of each specimen.
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Again, the manual pretreatment protocol was robust, although two of the ALK negative specimens (24 and 36) failed to processes adequately for interpretation, a consistent observation across all of the sites, except Milan. We observed VP 2000 results consistent to those of the training set in Lyon, Berlin and Rennes, where 30%, 20% and 20% of the specimens failed pretreatment respectively. In Milan, there was a 100% success rate on all of the specimens, again confirming the feasibility of a highly robust front-end automation protocol for ALK FISH on the VP 2000 instrument.
With respect to the interpretation of the ALK FISH assay, two of the sites, Rennes and Berlin, utilized scanning systems to capture high resolution images, which were then enumerated manually on computer screens. In Antwerp, Lyon and Milan, fully automated back-end scanning analysis systems were employed.
In Rennes, when the specimens were successfully pretreated, the concordance between positive and negative ALK FISH between the Rennes and Antwerp enumerations was 100%.
In Berlin we observed two disconcordant cases (specimens 27 and 39), which were misclassified as ALK negative. Similar, in Lyon two cases (specimen 25 and 39) were misclassified as ALK negative. Specimen 27 and 39 were the two most challenging ALK positive cases of the test set as they both contained less than 30% of cells with translocation (as determined by Antwerp, Rennes and Milan).
Using automated analysis algorithms, the BioView system in Antwerp, as well as the Ikonisys system in Milan produced highly concordant results (100%) for all of the specimens that were successfully pretreated. Interestingly, in Milan, even the two cases that failed pretreatment at the other sites, produced ALK negative results.
Reanalysis of difficult specimens using SoloWeb
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Unfortunately a number of the specimens failed to be processed successfully on the VP 2000 instrument in Lyon, Rennes and Berlin. We wanted to assess if these cases could potentially be remotely analyzed by each site if given access to the raw images utilizing an innovate software developed by BioView, called SoloWeb. The SoloWeb software allowed each of the three sites to log into the BioView captured cases from Antwerp and reinterpret each case over the internet. The results of this reanalysis are also presented in Table 2 . With the exception of one case for Lyon (specimen 39) there was 100% concordance between the interpretations in Antwerp, Rennes, and Berlin. Interestingly, even the two disconcordant cases from Berlin's manual computer image-based read and one of the two disconcordant cases from Lyon's BioView based analysis, were correctly reclassified as ALK positive using the BioView-based analysis algorithms on the images of the tumor regions selected by
Antwerp.
Discussion
In this study, we evaluated the feasibility for ALK FISH automation by comparing results of manual testing with those of automated testing. In a first phase of the study, 20 slides were sent to four European laboratories to assess the success of the front-end pretreatment protocol, and to allow for training of a back-end system. In a second phase, 20 blinded slides were sent to the participating laboratories to access their respective back-end scanning protocols.
Taken together, the results of this study suggest that automation of ALK FISH on the VP 2000 instrument is feasible; however the choice of pretreatment chemistry is critical to obtaining robust results, as the manual protocol reagents for NSCLC could not simply be Abbreviations: Inf = informative result, fail = uninformative result, un = undefined 
